位置:首页 > 蛋白库 > MAZG_ECOLI
MAZG_ECOLI
ID   MAZG_ECOLI              Reviewed;         263 AA.
AC   P0AEY3; P33646; Q2MA51;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   03-AUG-2022, entry version 118.
DE   RecName: Full=Nucleoside triphosphate pyrophosphohydrolase;
DE            Short=NTP-PPase;
DE            EC=3.6.1.8;
GN   Name=mazG; OrderedLocusNames=b2781, JW2752;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RA   Aizenman E., Glaser G.;
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, SUBUNIT, AND INTERACTION WITH
RP   ERA.
RX   PubMed=12218018; DOI=10.1128/jb.184.19.5323-5329.2002;
RA   Zhang J., Inouye M.;
RT   "MazG, a nucleoside triphosphate pyrophosphohydrolase, interacts with Era,
RT   an essential GTPase in Escherichia coli.";
RL   J. Bacteriol. 184:5323-5329(2002).
RN   [5]
RP   FUNCTION IN NUTRITIONAL STRESS RESPONSE, ACTIVITY REGULATION, AND OPERON
RP   STRUCTURE.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574, and
RC   K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16390452; DOI=10.1111/j.1365-2958.2005.04956.x;
RA   Gross M., Marianovsky I., Glaser G.;
RT   "MazG -- a regulator of programmed cell death in Escherichia coli.";
RL   Mol. Microbiol. 59:590-601(2006).
RN   [6]
RP   FUNCTION AS PYROPHOSPHOHYDROLASE, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20529853; DOI=10.1074/jbc.m109.088872;
RA   Lu L.D., Sun Q., Fan X.Y., Zhong Y., Yao Y.F., Zhao G.P.;
RT   "Mycobacterial MazG is a novel NTP pyrophosphohydrolase involved in
RT   oxidative stress response.";
RL   J. Biol. Chem. 285:28076-28085(2010).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF MUTANT ALA-119/ALA-257 IN COMPLEX
RP   WITH ATP, FUNCTION IN NUTRITIONAL STRESS RESPONSE, CATALYTIC ACTIVITY,
RP   MUTAGENESIS OF ARG-95; LYS-119; LYS-168; GLU-171; GLU-172; GLU-175;
RP   LYS-189; GLU-192; GLU-193; ASP-196; LYS-222; ARG-226; TRP-253 AND LYS-257,
RP   AND SUBUNIT.
RX   PubMed=18353782; DOI=10.1074/jbc.m800479200;
RA   Lee S., Kim M.H., Kang B.S., Kim J.S., Kim G.H., Kim Y.G., Kim K.J.;
RT   "Crystal structure of Escherichia coli MazG, the regulator of nutritional
RT   stress response.";
RL   J. Biol. Chem. 283:15232-15240(2008).
CC   -!- FUNCTION: Involved in the regulation of bacterial cell survival under
CC       conditions of nutritional stress. Regulates the type II MazE-MazF
CC       toxin-antitoxin (TA) system which mediates programmed cell death (PCD).
CC       This is achieved by lowering the cellular concentration of (p)ppGpp
CC       produced by RelA under amino acid starvation, thus protecting the cell
CC       from the toxicity of MazF. Reduction of (p)ppGpp can be achieved by
CC       direct degradation of (p)ppGpp or by degradation of NTPs, which are
CC       substrates for (p)ppGpp synthesis by RelA.
CC       {ECO:0000269|PubMed:16390452, ECO:0000269|PubMed:18353782,
CC       ECO:0000269|PubMed:20529853}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = AMP + diphosphate + H(+); Xref=Rhea:RHEA:14245,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:456215; EC=3.6.1.8;
CC         Evidence={ECO:0000269|PubMed:12218018, ECO:0000269|PubMed:18353782};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Inhibited by the MazE-MazF complex.
CC       {ECO:0000269|PubMed:16390452}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.34 mM for dATP (at pH 9.6 and at 37 degrees Celsius in the
CC         presence of 5 mM magnesium) {ECO:0000269|PubMed:20529853};
CC         KM=0.71 mM for UTP (at pH 9.6 and at 37 degrees Celsius in the
CC         presence of 5 mM magnesium) {ECO:0000269|PubMed:20529853};
CC         KM=0.36 mM for 8-oxo-dGTP (at pH 9.6 and at 37 degrees Celsius in the
CC         presence of 5 mM magnesium) {ECO:0000269|PubMed:20529853};
CC         Vmax=0.23 nmol/min/ug enzyme for 8-oxo-dGTP (at pH 9.6 and at 37
CC         degrees Celsius in the presence of 5 mM magnesium)
CC         {ECO:0000269|PubMed:20529853};
CC         Vmax=1.9 nmol/min/ug enzyme for dATP (at pH 9.6 and at 37 degrees
CC         Celsius in the presence of 5 mM magnesium)
CC         {ECO:0000269|PubMed:20529853};
CC         Vmax=1.9 nmol/min/ug enzyme for dUTP (at pH 9.6 and at 37 degrees
CC         Celsius in the presence of 5 mM magnesium)
CC         {ECO:0000269|PubMed:20529853};
CC   -!- SUBUNIT: Homodimer. Interacts with Era. {ECO:0000269|PubMed:12218018,
CC       ECO:0000269|PubMed:18353782}.
CC   -!- INTERACTION:
CC       P0AEY3; P0AEH5: elaB; NbExp=2; IntAct=EBI-554166, EBI-552130;
CC       P0AEY3; P0A6F5: groEL; NbExp=2; IntAct=EBI-554166, EBI-543750;
CC   -!- INDUCTION: Part of the relA-mazE-mazF-mazG operon, there is also a
CC       second mazE-mazF specific promoter which is negatively autoregulated.
CC   -!- SIMILARITY: Belongs to the nucleoside triphosphate pyrophosphohydrolase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04039; AAA03240.1; -; Unassigned_DNA.
DR   EMBL; U29580; AAA69291.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75823.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76855.1; -; Genomic_DNA.
DR   PIR; A65060; A65060.
DR   RefSeq; NP_417261.1; NC_000913.3.
DR   RefSeq; WP_001071648.1; NZ_STEB01000030.1.
DR   PDB; 3CRA; X-ray; 2.10 A; A/B=1-263.
DR   PDB; 3CRC; X-ray; 3.00 A; A/B=1-263.
DR   PDBsum; 3CRA; -.
DR   PDBsum; 3CRC; -.
DR   AlphaFoldDB; P0AEY3; -.
DR   SMR; P0AEY3; -.
DR   BioGRID; 4262299; 19.
DR   BioGRID; 851584; 1.
DR   DIP; DIP-48054N; -.
DR   IntAct; P0AEY3; 7.
DR   STRING; 511145.b2781; -.
DR   jPOST; P0AEY3; -.
DR   PaxDb; P0AEY3; -.
DR   PRIDE; P0AEY3; -.
DR   EnsemblBacteria; AAC75823; AAC75823; b2781.
DR   EnsemblBacteria; BAE76855; BAE76855; BAE76855.
DR   GeneID; 66673352; -.
DR   GeneID; 947254; -.
DR   KEGG; ecj:JW2752; -.
DR   KEGG; eco:b2781; -.
DR   PATRIC; fig|1411691.4.peg.3954; -.
DR   EchoBASE; EB0567; -.
DR   eggNOG; COG3956; Bacteria.
DR   HOGENOM; CLU_038356_0_1_6; -.
DR   InParanoid; P0AEY3; -.
DR   OMA; HPHIYGD; -.
DR   PhylomeDB; P0AEY3; -.
DR   BioCyc; EcoCyc:EG10572-MON; -.
DR   BioCyc; MetaCyc:EG10572-MON; -.
DR   SABIO-RK; P0AEY3; -.
DR   EvolutionaryTrace; P0AEY3; -.
DR   PRO; PR:P0AEY3; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047693; F:ATP diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0047429; F:nucleoside-triphosphate diphosphatase activity; IDA:EcoCyc.
DR   GO; GO:0009267; P:cellular response to starvation; IMP:EcoCyc.
DR   GO; GO:0046061; P:dATP catabolic process; IBA:GO_Central.
DR   GO; GO:0006203; P:dGTP catabolic process; IBA:GO_Central.
DR   GO; GO:0046076; P:dTTP catabolic process; IBA:GO_Central.
DR   GO; GO:0046081; P:dUTP catabolic process; IBA:GO_Central.
DR   GO; GO:0046047; P:TTP catabolic process; IBA:GO_Central.
DR   GO; GO:0046052; P:UTP catabolic process; IBA:GO_Central.
DR   InterPro; IPR004518; MazG_cat.
DR   InterPro; IPR011551; NTP_PyrPHydrolase_MazG.
DR   PANTHER; PTHR30522; PTHR30522; 1.
DR   Pfam; PF03819; MazG; 2.
DR   TIGRFAMs; TIGR00444; mazG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Hydrolase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Reference proteome.
FT   CHAIN           1..263
FT                   /note="Nucleoside triphosphate pyrophosphohydrolase"
FT                   /id="PRO_0000096248"
FT   BINDING         168..172
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   BINDING         172
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         175
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   BINDING         175
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         189..192
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   BINDING         193
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         196
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   BINDING         196
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         222..226
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   BINDING         253
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         95
FT                   /note="R->A: Does not affect nucleotide
FT                   pyrophosphohydrolysis activity."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         119
FT                   /note="K->A: Does not affect the nucleotide
FT                   pyrophosphohydrolysis activity."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         168
FT                   /note="K->A: Does not affect nucleotide
FT                   pyrophosphohydrolysis activity."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         171
FT                   /note="E->A: Does not affect nucleotide
FT                   pyrophosphohydrolysis activity."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         172
FT                   /note="E->A: Loss of pyrophosphohydrolysis activity against
FT                   both ATP and dTTP."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         175
FT                   /note="E->A: Does not affect nucleotide
FT                   pyrophosphohydrolysis activity."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         189
FT                   /note="K->A: Does not affect nucleotide
FT                   pyrophosphohydrolysis activity."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         192
FT                   /note="E->A: Does not affect nucleotide
FT                   pyrophosphohydrolysis activity."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         193
FT                   /note="E->A: Loss of pyrophosphohydrolysis activity against
FT                   both ATP and dTTP."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         196
FT                   /note="D->A: Loss of pyrophosphohydrolysis activity against
FT                   both ATP and dTTP."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         222
FT                   /note="K->A: Loss of pyrophosphohydrolysis activity against
FT                   both ATP and dTTP."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         226
FT                   /note="R->A: Loss of pyrophosphohydrolysis activity against
FT                   both ATP and dTTP."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         253
FT                   /note="W->A: Loss of pyrophosphohydrolysis activity against
FT                   both ATP and dTTP."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   MUTAGEN         257
FT                   /note="K->A: Loss of pyrophosphohydrolysis activity against
FT                   both ATP and dTTP."
FT                   /evidence="ECO:0000269|PubMed:18353782"
FT   CONFLICT        226
FT                   /note="Missing (in Ref. 1; AAA03240)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..15
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   TURN            17..19
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           24..26
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           29..48
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           52..74
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           81..93
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           115..123
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:3CRC"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:3CRC"
FT   HELIX           141..153
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   TURN            154..156
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           162..181
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   STRAND          182..184
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           187..207
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           212..236
FT                   /evidence="ECO:0007829|PDB:3CRA"
FT   HELIX           249..258
FT                   /evidence="ECO:0007829|PDB:3CRA"
SQ   SEQUENCE   263 AA;  30412 MW;  C396BC3B9378D2BE CRC64;
     MNQIDRLLTI MQRLRDPENG CPWDKEQTFA TIAPYTLEET YEVLDAIARE DFDDLRGELG
     DLLFQVVFYA QMAQEEGRFD FNDICAAISD KLERRHPHVF ADSSAENSSE VLARWEQIKT
     EERAQKAQHS ALDDIPRSLP ALMRAQKIQK RCANVGFDWT TLGPVVDKVY EEIDEVMYEA
     RQAVVDQAKL EEEMGDLLFA TVNLARHLGT KAEIALQKAN EKFERRFREV ERIVAARGLE
     MTGVDLETME EVWQQVKRQE IDL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024